# Treatment of Head & Neck Cancer With Chemotherapy and Radiation

> **NCT00392704** · PHASE2 · COMPLETED · sponsor: **SCRI Development Innovations, LLC** · enrollment: 60 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** Bevacizumab
- **DRUG:** Erlotinib
- **DRUG:** Paclitaxel
- **DRUG:** 5-FU
- **RADIATION:** Radiation Therapy

## Key facts

- **NCT ID:** NCT00392704
- **Lead sponsor:** SCRI Development Innovations, LLC
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2008-08
- **Final completion:** 2012-05
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2013-02-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00392704

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00392704, "Treatment of Head & Neck Cancer With Chemotherapy and Radiation". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00392704. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*